N
Nektar Therapeutics D
D
NKTR
25.020
USD
0.42
(1.71%)
مغلق
حجم التداول
28,750
الربح لكل سهم
-12
العائد الربحي
-
P/E
-3
حجم السوق
432,859,085
الأخبار المقالات
العنوان: Nektar Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.